CellSight Technologies, Inc. is a San Francisco-based company specializing in the development of imaging tools for clinical trials and research in the field of immunotherapy. Their innovative PET tracer, VisAcT, allows for the visualization of the whole body immune response to immunotherapy, aiding in patient selection and treatment assessment.
With a focus on cancer immunotherapies, CellSight's technology provides valuable insights into the effectiveness of immunotherapy and helps identify patients who may require immune priming before treatment. Their collaborative work with renowned institutions and publications in the field demonstrates their commitment to advancing the understanding and application of immunotherapy in the fight against cancer.
Generated from the website